Successful glycemic control using a flash glucose monitoring system for a pregnant woman with diabetes: A case report

被引：2

作者：

Kishimoto M. ^{[1
,2
]}

Tamada S. ^{[3
]}

Oshiba Y. ^{[1
,3
]}

机构：

[1] International University of Health and Welfare, Clinical Research Center, Department of Medicine, Tokyo

[2] Sanno Hospital, Department of Internal Medicine, 8-10-16 Akasaka Minato, Tokyo

[3] Sanno Hospital, Department of Obstetrics and Gynecology, 8-10-16 Akasaka Minato, Tokyo

来源：

Journal of Diabetes & Metabolic Disorders | / 16卷 / 1期

关键词：

Flash glucose monitoring system; Gestational diabetes mellitus; Impaired glucose tolerance; Insulin;

D O I：

10.1186/s40200-017-0327-1

中图分类号：

学科分类号：

摘要：

Background: Glucose control for pregnant women with glucose intolerance is important, as hyperglycemia may adversely affect the mother and the fetus. Case presentation: We report the case of a pregnant Japanese woman who experienced gestational diabetes mellitus during her first pregnancy and developed impaired glucose tolerance after the delivery. During her second pregnancy with twins, she required up to 75 units of injected insulin to control her postprandial hyperglycemia and occasionally experienced hypoglycemia. We used a newly developed flash glucose monitoring system, which allowed her to successfully achieve ideal glycemic control and experience an uncomplicated delivery. Conclusion: We suggest that this flash glucose monitoring system may be clinically effective for similar cases that involve pregnant women with abnormal glucose tolerance. © 2017 The Author(s).

引用

共 28 条

[1]

Chen P., Wang S., Ji J., Et al., Risk factors and management of gestational diabetes, Cell Biochem Biophys, 71, pp. 689-694, (2015)

[2]

Metzger B.E., Lowe L.P., Dyer A.R., Et al., Hyperglycemia and adverse pregnancy outcomes, N Engl J Med, 358, pp. 1991-2002, (2008)

[3]

Management of diabetes in pregnancy. Sec. 13. In standards of medical Care in Diabetes-2017, Diabetes Care, 40, pp. S114-S119, (2017)

[4]

Holmes V.A., Young I.S., Patterson C.C., Et al., Diabetes and Pre-eclampsia Intervention Trial Study Group. Optimal glycemic control, pre-eclampsia, and gestational hypertension in women with type 1 diabetes in the diabetes and pre-eclampsia intervention trial, Diabetes Care, 34, pp. 1683-1688, (2011)

[5]

Dabelea D., Hanson R.L., Lindsay R.S., Et al., Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships, Diabetes, 49, pp. 2208-2211, (2000)

[6]

Kim C., Newton K.M., Knopp R.H., Gestational diabetes and the incidence of type 2 diabetes: a systematic review, Diabetes Care, 25, pp. 1862-1868, (2002)

[7]

O'Sullivan J.B., Diabetes mellitus after GDM, Diabetes, 40, pp. 131-135, (1991)

[8]

Bellamy L., Casas J.P., Hingorani A.D., Et al., Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis, Lancet, 373, pp. 1773-1779, (2009)

[9]

Bolinder J., Antuna R., Geelhoed-Duijvestijn P., Et al., Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial, Lancet, 388, pp. 2254-2263, (2016)

[10]

Haak T., Hanaire H., Ajjan R., Et al., Flash glucose-sensing technology as a replacement for blood glucose monitoring for the Management of Insulin-Treated Type 2 diabetes: a multicenter, open-label randomized controlled trial, Diabetes Ther, 8, pp. 55-73, (2017)

← 1 2 3 →